← Back to Search

Behavioral Intervention

Pilot for Liver Cirrhosis (LiverPal Trial)

N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up time frame: up to 1 year
Awards & highlights

LiverPal Trial Summary

This trial studies a palliative care team helping people with advanced liver disease manage discomforting physical and emotional symptoms.

Eligible Conditions
  • Liver Cirrhosis

LiverPal Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~time frame: up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and time frame: up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
LiverPal intervention refinement

LiverPal Trial Design

1Treatment groups
Experimental Treatment
Group I: PilotExperimental Treatment1 Intervention
Inpatient longitudinal palliative care intervention that includes the following domains: Therapeutic relationship: Developing trust and credibility with patients and their families Symptom management: Proactive symptom management for common advanced liver disease symptoms including pain, fatigue, anorexia, breathlessness, depression and anxiety Coping with illness: Introduction of strategies to improve adjustment and meaning in life; bolstering caregiver coping Prognostic awareness and illness understanding: Assessing patients' level of prognostic awareness and discussing strategies to help patients cope with uncertainty Treatment decision-making: Supporting patients and caregivers in their medical decision-making and assessing their values in decision-making End-of-life care: Review/discuss selection of healthcare proxy, preferences for end-of-life care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LiverPal Intervention
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,330 Total Patients Enrolled
8 Trials studying Liver Cirrhosis
645 Patients Enrolled for Liver Cirrhosis
American Association for the Study of Liver DiseasesOTHER
5 Previous Clinical Trials
184 Total Patients Enrolled
1 Trials studying Liver Cirrhosis
76 Patients Enrolled for Liver Cirrhosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Connecticut
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease
Nneka nnaoke Ufere 2022. "LiverPAL: A Pilot Study of Inpatient Palliative Care for Patients With Advanced Liver Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04953143.
~8 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top